載入...
Targeting the Ras pathway in pediatric hematologic malignancies
PURPOSE: Ras pathway mutations are one of the most common type of alterations in pediatric hematologic malignancies and are frequently associated with adverse outcomes. Despite ongoing efforts to use targeted treatments, there remain no food and drug administration (FDA) approved medications specifi...
Na minha lista:
| 發表在: | Curr Opin Pediatr |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7880552/ https://ncbi.nlm.nih.gov/pubmed/33394740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOP.0000000000000981 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|